Clinical Guest Contributors

  1. This Real-World Example Illustrates The Power Of Patient Centricity In Clinical Trials 11/19/2025

    Ardelyx Chief Patient Officer Laura Williams, MD, MPH, reflects on how patients with chronic kidney disease (CKD) successfully guided Ardelyx’s clinical trial program.

  2. Begin Your AI-Led Digital Clinical Transformation With A Phased Approach 11/18/2025

    Discover how to establish a holistic AI-led digital strategy, starting with a top-down, phased approach.

  3. Phages As A Pharmaceutical: New EMA Guidance On Antimicrobial Drug Development 11/17/2025

    The EMA has now issued a draft guidance on quality aspects of phage therapy medicinal products. Rising antimicrobial resistance has renewed interest in bacteriophages to fight pathogens.

  4. New Initiative Helps Researchers Enroll Healthy Volunteers In High Impact Trials 11/17/2025

    1Day Sooner’s Director of Clinical Trials Circe MacDonald talks about their new Cooperative Patient Organization, the recruitment gaps it hopes to fill, and the importance of incorporating participant input. 

  5. Everyone Talks About Site Selection — But Few Actually Get It Right 11/14/2025

    The site selection process is complicated by outdated data, limited operational insight, and overreliance on reputation. Discover some practical ways to evaluate site feasibility for your next trial.

  6. Non-Invasive Brain-Computer Interface Trial Balances Regulatory Requirements With Patient Needs 11/13/2025

    Cognixion CTO Chris Ullrich introduces the Axon-R Nucleus bio-sensing hub and discusses its feasibility trial, highlighting the importance of patient input, caregiver quality of life, and regulatory support. 

  7. Heading For An M&A? Understand The Risks And Mitigation Strategies For Clinical Trial Agreements 11/10/2025

    Learn the key considerations to anticipate and mitigate risks that CTAs and diligence in the clinical trial space present during mergers and acquisitions (M&As).

  8. Sites Are 3X Likely To Die In The First Year Than New Businesses 11/7/2025

    Milken Institute Health Director of Research Andrew Friedson, Ph.D., reveals the stark truth of site survivability and discusses how factors like available population and local economic conditions factor into survival rates.

  9. Sponsors Collect Too Much "Non-Essential" Data, Say Tufts And TransCelerate 11/6/2025

    A collaboration between Tufts CSDD, Tufts School of Medicine, and TransCelereate BioPharma revealed just how much extra data sponsors are collecting — and why that's a problem.

  10. Global Implications Of Zero Tariffs On Indian Pharma Exports To China 11/5/2025

    Discover the worldwide impacts of China’s zero-tariff policy on Indian pharmaceutical drugs.